Abstract

The use of selective serotonin reuptake inhibitors (SSRI) during pregnancy has increased tremendously, but the consequences for the offspring remain largely unclear. Several studies have described potential effects of perinatal SSRI-exposure on neurobehavioral outcomes using simplified rodent test set-ups, however these set-ups only assess a small fraction of the behavior. For translational purposes it is important to take the environmental influences into account which children are exposed to in real life. By using a seminatural environmental set-up, this study is the first to assess behavioral outcomes in offspring exposed to perinatal SSRI exposure under seminatural circumstances. Mothers received daily the SSRI fluoxetine (FLX, 10 mg/kg p.o.) or vehicle (CTR) from gestational day 1 until postnatal day 21. To assess the effect of FLX exposure during early development, female and male offspring were behaviorally tested in the seminatural environment at adulthood. Baseline behavior was measured in addition to responses during and after stressful white-noise events. Behavior was observed on two days, day 4 on which females were sexually non-receptive, and day 7, on which females were sexual receptive. Perinatal FLX exposure reduced general activity in females and increased behavior related to a social context in both males and females. After a stressful white-noise event some behaviors switched. Whereas FLX-females switch from resting socially to resting more solitarily, FLX-males show an increase in self-grooming behavior after the stressor and showed more freezing behavior in the open area. We conclude that perinatal FLX exposure leads to alterations in social and stress-coping behaviors in adulthood, when observed in a seminatural environment. Whether these adaptations in behavior are advantageous or disadvantageous remains to be established.

Highlights

  • Depressive symptoms frequently occur during pregnancy and can affect the developing child in a profound way

  • Since we explored all the behaviors that the rats performed in the seminatural environment, this experiment generated a lot of data

  • Overall, we conclude that perinatal selective serotonin reuptake inhibitors (SSRI) exposure causes adaptations in social and stresscoping behaviors at adulthood

Read more

Summary

Introduction

Depressive symptoms frequently occur during pregnancy and can affect the developing child in a profound way. Selective serotonin reuptake inhibitors (SSRIs) have gained acceptance as medication during pregnancy, which resulted in an increase in the prescription rate in pregnant women (Alwan et al, 2011; Ververs et al, 2006). By blocking the serotonin transporter (SERT), SSRIs inhibit the reuptake of serotonin (5HT) into the presynaptic nerve terminals, which results in an increase in the synaptic concentration of 5-HT. 5-HT mainly acts as a modulatory neurotransmitter regulating emotion, stress responses, sleep, learning, cognition, and attention (Canli and Lesch, 2007). On the other hand, 5-HT acts as a neurotrophic factor, regulating cell division, differentiation, migration, and synaptogenesis (Azmitia, 2001; Gaspar et al, 2003). It is assumed that changes in 5-HT levels during in utero neurodevelopment have the potential to affect these processes as well as subsequent serotonergic function and vulnerability to affective disorders (Lesch and Mossner, 1998)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call